Drug

D0883 | digitoxin

Molecular Formula C41H64O13
Molecular Weight 764.9
Structure
State solid

C

C01AA04 Digitoxin


[C01AA] Digitalis glycosides


[C01A] CARDIAC GLYCOSIDES


[C01] CARDIAC THERAPY


[C] Cardiovascular system


Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 0.16±0.05 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 0.06 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL rat hepatocytes MMP assay Negative IC50 163

Pictogram Signal Statements Precautionary Statement Codes
Danger

H301: Toxic if swallowed [Danger Acute toxicity, oral]


H331: Toxic if inhaled [Danger Acute toxicity, inhalation]


H373 **: Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]


P260, P261, P264, P270, P271, P301+P310, P304+P340, P311, P314, P321, P330, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)
Danger

Aggregated GHS information provided by 202 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.


H301+H331 (76.24%): Toxic if swallowed or if inhaled [Danger Acute toxicity, oral


acute toxicity, inhalation]


H301 (98.02%): Toxic if swallowed [Danger Acute toxicity, oral]


H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]


H373 (99.5%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P260, P261, P264, P270, P271, P301+P310, P304+P340, P311, P314, P321, P330, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)
Danger

H301: Toxic if swallowed [Danger Acute toxicity, oral]


H331: Toxic if inhaled [Danger Acute toxicity, inhalation]


H373: Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]


P260, P261, P264, P270, P271, P301+P310, P304+P340, P311, P314, P321, P330, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)
Danger

H301: Toxic if swallowed [Danger Acute toxicity, oral]


H331: Toxic if inhaled [Danger Acute toxicity, inhalation]


H373: Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]


P260, P261, P264, P270, P271, P301+P310, P304+P340, P311, P314, P321, P330, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)

Organism Test type Route Dose (normalized dose) Effect Source
cat LDLo intravenous 343ug/kg (0.343mg/kg) Journal of the American Pharmaceutical Association. Vol. 27, Pg. 761, 1938.
guinea pig LDLo intravenous 777ug/kg (0.777mg/kg) Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 195, 1960.
man TDLo oral 240ug/kg (0.24mg/kg) gastrointestinal: nausea or vomiting Sammlung von Vergiftungsfaellen. Vol. 10, Pg. 141A, 1939.
rat LDLo intravenous 12mg/kg (12mg/kg) Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 177, Pg. 60, 1934.
pigeon LDLo intravenous 470ug/kg (0.47mg/kg) Proceedings of the Society for Experimental Biology and Medicine. Vol. 89, Pg. 99, 1955.


  • (3beta,5beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-14-hydroxycard-20(22)-enolide 071D636 16732-EP2280955A2
    16732-EP2280980A1 16732-EP2292612A2 16732-EP2300441A1
    16732-EP2301938A1 16732-EP2303866A2 16732-EP2307386A1
    16732-EP2315764A2 16732-EP2376427A1 16732-EP2376433A1
    3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13 3beta-[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyloxy]-14-hydroxy-5beta-card-20(22)-enolide
    3beta-[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyloxy]-14-hydroxy-5beta-card-20(22)-enolide 4-((1S,2S,5S,11S,7R,10R,14R,15R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-methyl (2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3,4,5 ,6-tetrahydropyran-2-yloxy)](4S,5S,2R,6R)- 4-((1S,2S,5S,11S,7R,10R,14R,15R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-methyl (2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3,4,5 ,6-tetrahydropyran-2-yloxy)](4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3,4,5,6-tetrah ydropyran-2-yloxy)
    4-((3S,5R,8R,9S,10S,13R,14S,17R)-3-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one 4-[(1S,2S,5S,7R,10R,11S,14R,15R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one 4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one
    4-hydroxy-6-methyl(2H-3,4,5,6-tetrah ydropyran-2-yloxy)}-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0<11,15>]h eptadec-14-yl)-5-hydrofuran-2-one 5beta,20(22)-Cardenolide-3beta,14-diol-3-(O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-[1-->4]-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-[1-->4]-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy 6467-EP1441224A2
    6467-EP2270011A1 71-63-6 A572A148-EC30-47D2-A32A-C9D8A93F8EFC
    ACon0_000319 ACon1_000610 AKOS015915863
    Acedoxin Asthenthilo BDBM46356
    BRD-K63668566-001-01-7 BRN 0076678 C06955
    C41H64O13 CAS-71-63-6 CCG-208538
    CCRIS 7116 CHEBI:28544 CHEMBL254219
    CS-5502 Card-20(22)-enolide, 3-((O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)- Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy, (3beta,5beta)-
    Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)- Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)- Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)-;
    Cardidigin Cardigin Carditalin
    Carditoxin Caswell No. 349 Coramedan
    Cristapurat Crystalline Crystalline digitalin
    Crystodigin Crystodigin (TN) D00297
    D0542 DB01396 DSSTox_CID_2933
    DSSTox_GSID_22933 DSSTox_RID_76793 DTXSID0022933
    De-Tone Digicor Digilong
    Digimerck Digipural Digisidin
    Digitalin, crystalline Digitaline Digitaline cristallisee
    Digitaline nativelle DigitoXin, USP Digitoksim
    Digitoksin Digitophyllin Digitossina
    Digitossina [DCIT] Digitoxigenin tridigitoxoside Digitoxigenin-tridigitoxosid
    Digitoxigenin-tridigitoxosid [German] Digitoxin (JAN/USP/INN) Digitoxin [USP:INN:BAN:JAN]
    Digitoxin, >=92% (HPLC), powder Digitoxin, British Pharmacopoeia (BP) Reference Standard Digitoxin, European Pharmacopoeia (EP) Reference Standard
    Digitoxin, United States Pharmacopeia (USP) Reference Standard Digitoxina Digitoxina [INN-Spanish]
    Digitoxine Digitoxine [INN-French] Digitoxinum
    Digitoxinum [INN-Latin] Digitoxoside Digitoxosidum
    Digitrin Ditaven E90NZP2L9U
    EINECS 200-760-5 EPA Pesticide Chemical Code 097002 GTPL6782
    Glucodigin HSDB 215 HY-B1357
    LMST01120018 Lanatoxin MCULE-8291336831
    MCULE-9783596421 MEGxp0_001901 MFCD00003686
    MLS000069787 Mono-digitoxid Mono-digitoxid [German]
    Mono-glycocard Monodigitoxoside Myodigin
    NCGC00142623-02 NCGC00142623-03 NCGC00142623-04
    NCGC00142623-05 NCGC00142623-05_C41H64O13_Crystodigin NCGC00159428-02
    NCGC00255265-01 NSC 7529 NSC-7529
    NSC7529 Natigal Purodigin
    Purodigin, crystalline Purpurid Q-100791
    Q423890 REGID_for_CID_441207 SBI-0051348.P003
    SC-43721 SCHEMBL20940 SMP1_000096
    SMR000058529 SR-01000721879-2 ST072187
    Tardigal Tox21_111659 Tox21_111659_1
    Tox21_302269 Tri-digitoxoside [German] UNII-3899510F8M component WDJUZGPOPHTGOT-XUDUSOBPSA-N
    UNII-E90NZP2L9U Unidigin WDJUZGPOPHTGOT-XUDUSOBPSA-N
    Y0070 Z1558290128 ZINC95862733
    cid_441207 digitoxin

    DrugBank Name digitoxin
    DrugBank DB01396
    CAS Number 1339-93-1, 71-63-6, 8006-96-0, 87112-48-9
    PubChem Compound 441207
    KEGG Compound ID C06955
    KEGG Drug D00297
    ChEBI 28544